Human Parvovirus B19: Understanding its rising impact on public health
Human parvovirus B19, discovered in the 1970s, has become a significant concern in public health, particularly due to its ability to cause severe complications in ... Read More
Appili Therapeutics begins Phase 3 clinical trial for Avigan in fight against Covid-19
Appili Therapeutics, a Canadian infectious disease biopharmaceutical company, has announced a major milestone in its fight against Covid-19: the commencement of the Phase 3 clinical ... Read More